search
Back to results

Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream (BLOC-FEMPOP)

Primary Purpose

Peripheral Arterial Occlusive Disease

Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
levobupivacaine, clonidine
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peripheral Arterial Occlusive Disease focused on measuring Nerve block, Femoropopliteal bypass, Postoperative analgesia, Peripheral circulation, Levobupivacaine, Clonidine, Pain

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients to benefit a planned femoropopliteal bypass through PAOD stage II or III.
  • Aged 18 to 80 years.
  • Having given their consent.
  • Affiliated with a social security scheme.

Exclusion Criteria:

  • Patients with PAOD stage I or IV.
  • Chronic respiratory failure.
  • Severe coronary insufficiency.
  • Renal or hepatic impairment.
  • Patients with chronic pain or preoperative long-term opioid treatment.
  • Patients with cognitive impairment (judged by the investigator) that may interfere with:

    • informed consent,
    • the collection of endpoints,
    • the use of patient-controlled analgesia.
  • Severe abnormality of hemostasis (platelets <80.000 / ml) and / or of coagulation (PT <50%, factor V <50%).
  • Patients with diabetes mellitus and / or diabetic neuropathy.
  • Pregnant or nursing women, women of childbearing age.
  • Refusal of the protocol.
  • Minor or major protected patients.
  • Contraindications to one of the following products:

levobupivacaine, clonidine, morphine, paracetamol, nefopam.

- Patients with a contra-indication to the administration of sufentanil: hypersensitivity to any component, hypersensitivity to morphine, hypersensitivity to opiates.

Sites / Locations

  • CHU Clermont-Ferrand

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

NaC1

Levobupivacaine + clonidine

Arm Description

The aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperatively assessed by morphine consumption.

The aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperatively assessed by morphine consumption.

Outcomes

Primary Outcome Measures

total morphine consumption

Secondary Outcome Measures

total morphine consumption
pain score at rest
pain score
pain score
total sufentanil consumption
rate of reoperation
mortality rate
sedation score
Hemodynamic tolerance
nausea
vomiting
Bleeding score

Full Information

First Posted
January 17, 2013
Last Updated
May 23, 2019
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
ARAMU Association
search

1. Study Identification

Unique Protocol Identification Number
NCT01785693
Brief Title
Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream
Acronym
BLOC-FEMPOP
Official Title
Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
January 30, 2013 (Actual)
Primary Completion Date
November 27, 2016 (Actual)
Study Completion Date
November 27, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
ARAMU Association

4. Oversight

5. Study Description

Brief Summary
The aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperatively assessed by morphine consumption. Applied to the patient at the beginning of general anesthesia, this technique could allow one hand, to reduce the need for opiates, on the other hand - due to anesthetized limb vasodilation - to improve tissue perfusion downstream.
Detailed Description
Course of the study Visit 1 (J-15 J-1): Pre-inclusion During a follow-up visit usual pathology, the doctor will propose to the patient to participate in the protocol. Information Form will be given to the patient to be read at home to maintain a sufficient time for reflection. Visit 2 (J-1): Pre-anesthetic, the eve of the intervention: During the pre-anesthetic consultation routine, the doctor will check the informed consent and then note the following information on the case report form: age, height, weight, sex of the patient. Visit 3 (J0): Surgery One hour before surgery the patient will receive premedication with Hydroxyzine (Atarax ®). Then the anesthetic team install patient in monitoring room so that the test products are administered according to the double-blind randomization schedule prepared in advance. When the block is made, the patient is brought into the operating room for general anesthesia and surgery. By the end of surgery, the following data will be collected in the case report form : Vital parameters (heart rate, blood pressure, PetCO2, SpO2) every 10 minutes and incidents. Time of injection tested products and time of induction of general anesthesia. Major Surgical times : incision, venous sampling when indicated, heparin bolus, clamping the superficial femoral artery, arterial unclamping, skin closure. Duration of operation (in minutes from the incision to skin closure). Intraoperative sufentanil consumption (micrograms). Monitoring and medical care in Post Anaesthesia Carry Unit (PACU): After surgery, the patient will be conducted in PACU. He will benefit from routine monitoring of vital parameters (heart rate, blood pressure, respiratory rate and SpO2). Then patient extubation, according to usual criteria, will be performed: extubation of the patient is the H0, when all the time measurement start. - H0: Extubation Morphine consumption will be measured continuously during the 72 first postoperative hours. rSO2 be measured by NIRS during the first 12 first postoperative hours. H0 +30 min: rating of pain (simple numerical scale) + sedation score H0 +60 min: rating of pain + sedation score H0 +90 min: rating of pain H0 +120 min: rating of pain + sedation score H0+4h: rating of pain + sedation score H0+8h: rating of pain + sedation score H0+12h: rating of pain H0+16h: rating of pain + sedation score H0+20h: rating of pain H0+24h: rating of pain + sedation score + morphine consumption with PCA and number of requests over the last 24 hours. H0+32h: rating of pain H0+40h: rating of pain H0+48h: rating of pain + morphine consumption with PCA and number of requests over the last 24 hours. H0+56h: rating of pain H0+64h: rating of pain H0+72h: rating of pain + morphine consumption with PCA and number of requests over the last 24 hours. At the end of PACU: rating of pain + sedation score Thereafter, recovery time of ambulation will be registered and duration of hospital stay, rate of reoperation within 30 post-operative days and 30-day survival. Adverse events will be collected to have information about hemodynamic tolerance of the products. The patient is then monitored in the usual care of the disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Occlusive Disease
Keywords
Nerve block, Femoropopliteal bypass, Postoperative analgesia, Peripheral circulation, Levobupivacaine, Clonidine, Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
47 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NaC1
Arm Type
Other
Arm Description
The aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperatively assessed by morphine consumption.
Arm Title
Levobupivacaine + clonidine
Arm Type
Other
Arm Description
The aim of this study is to assess, in patients scheduled for femoropopliteal bypass, the benefit of a double peripheral nerve block (femoral + sciatic) with levobupivacaine and clonidine in a single dose, performed before induction of general anaesthesia, on analgesia postoperatively assessed by morphine consumption.
Intervention Type
Drug
Intervention Name(s)
levobupivacaine, clonidine
Primary Outcome Measure Information:
Title
total morphine consumption
Time Frame
between hour 0 and hour 0+24h
Secondary Outcome Measure Information:
Title
total morphine consumption
Time Frame
between Hour 0 and Hour 0+72h
Title
pain score at rest
Time Frame
30, 60, 90 and 120 minutes after extubation
Title
pain score
Time Frame
every 4 hours during the 24 first post-operative hours
Title
pain score
Time Frame
every 8 hours during the next post-opeartive 48 hours
Title
total sufentanil consumption
Time Frame
between induction and extubation
Title
rate of reoperation
Time Frame
between day1 and day30
Title
mortality rate
Time Frame
at day 30
Title
sedation score
Time Frame
at hour0+30mn, at hour 0+1h, at hour 0+2h, at H0+4h, at hour 0+8h, at H0+16h, at hour 0+24h
Title
Hemodynamic tolerance
Time Frame
between day 1 and day 30
Title
nausea
Time Frame
between day 1 and day 30
Title
vomiting
Time Frame
between day 1 and day 30
Title
Bleeding score
Time Frame
between hour 0 and hour 0+24h

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients to benefit a planned femoropopliteal bypass through PAOD stage II or III. Aged 18 to 80 years. Having given their consent. Affiliated with a social security scheme. Exclusion Criteria: Patients with PAOD stage I or IV. Chronic respiratory failure. Severe coronary insufficiency. Renal or hepatic impairment. Patients with chronic pain or preoperative long-term opioid treatment. Patients with cognitive impairment (judged by the investigator) that may interfere with: informed consent, the collection of endpoints, the use of patient-controlled analgesia. Severe abnormality of hemostasis (platelets <80.000 / ml) and / or of coagulation (PT <50%, factor V <50%). Patients with diabetes mellitus and / or diabetic neuropathy. Pregnant or nursing women, women of childbearing age. Refusal of the protocol. Minor or major protected patients. Contraindications to one of the following products: levobupivacaine, clonidine, morphine, paracetamol, nefopam. - Patients with a contra-indication to the administration of sufentanil: hypersensitivity to any component, hypersensitivity to morphine, hypersensitivity to opiates.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe JOUVE
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
32769505
Citation
Charvin M, Longeras F, Jouve P, Cherprenet AL, Futier E, Pereira B, Duale C. Effects of adding a combined femoral and sciatic nerve block with levobupivacaine and clonidine to general anaesthesia in femoropopliteal bypass surgery: A randomised, double-blind, controlled trial. Eur J Anaesthesiol. 2020 Sep;37(9):787-795. doi: 10.1097/EJA.0000000000001263.
Results Reference
derived

Learn more about this trial

Interest of a Bi-truncal Nerve Block (Femoral + Sciatic) Extended, Systematically Associated With General Anesthesia, in the Femoropopliteal Bypass: Study of Post-operative Analgesia and Peripheral Circulation Downstream

We'll reach out to this number within 24 hrs